First Annual IMPPC Conference

Genetics, Epigenetics & Cancer Prediction
18-19 March 2010
Hotel Colon, Av Catedral, Barcelona

8.30 Registration
9.00 Welcome remarks
Joan Roca, General Director of Research , DIUE
9.15 Walter Bodmer. Univ. Oxford, Weatherall Institute of Molecular Medicine
Genetics & Epigenetics of Colorectal Cancer

Cancer Genetics

Eduard Serra & Mayka Sanchez (Chairs) IMPPC

10.00 Frank McCormick. UCSF Helen Diller Cancer Center. San Francisco.
Cancer Treatment Based on the Ras Pathway

10.40 Webster Cavenee. UCSD Ludwig Insitute for Cancer Research, San Francisco
Targeted Therapies: Why Do They Fail?
11.20 Coffee break
11.50 Gabriel Capella. Institut Català d’Oncologia (ICO), Barcelona
Genetic Diagnosis of Hereditary Colorectal
Cancer: Advances and Challenges

12.30 Miguel Angel Piris. Spanish National Cancer Research Center (CNIO), Madrid
Targeting the B-cell Receptor in Lymphomas
13.10 Lunch

Cancer Epigenetics

Fumi Yamamoto & Pepita Giménez (Chairs) IMPPC

15.00 Marcus Buschbeck. IMPPC, Barcelona
MacroH2A – a Novel Player in the Regulation
of Cell Fate
15.40 Susan Clark. Univ. New South Wales. Garvan
Institute of Medical Research.
Remodelling of the Cancer Epigenome

16.20 Miguel Àngel Peinado. IMPPC, Barcelona
Illuminating the Dark Side of the Epigenome
17.00 Coffee break
17.20 Manel Esteller. Cancer Epigenetics & Biology, Program (PEBC), IDIBELL, Barcelona
Cancer Epigenetics: from DNA Methylation
to Non-Coding RNAs

18.00 Manuel Perucho. IMPPC, Barcelona
A “Wear & Tear” Model Linking Epigenetic-Genetic Alterations with Aging & Cancer

Cancer Prediction

Lauro Sumoy & Ana Rojas (Chairs) IMPPC

09.00 Ian Tomlinson. Univ. Oxford, Wellcome Trust, Centre for Human Genetics
Colorectal Cancer Predisposition and the BMP Pathway

09.40 Albert Tenesa. Univ. Edinburgh, School of Molecular & Clinical Medicine
Common Genetic Variants and the Risk of Colorectal Cancer Onset
10.20 Agustín Ruiz. Neocodex, INC. Sevilla
Genome Wide Epistasis Analysis: Facts and Challenges
11.00 Coffee break
11.30 Jun Yokota. National Cancer Center Research Institute, Tokyo
Ethnic Differences in Lung Cancer Susceptibility

12.10 Allan Balmain. UCSF Helen Diller Cancer Center, San Francisco
Cancer Complexity: Lessons from Systems Genetics Analysis of Tumor Susceptibility
12.50 Miquel Gómez Clares, Director of the Director Plan for Scientific Policy of the Ministry of Health of the Generalitat of Catalonia
Closing remarks
13.00 Adjourn


Generalitat de Catalunya

Unió Europea


Universitat Autònoma de Barcelona

Ajuntament de Badalona

Institut Català de la Salut

Germans Trias i Pujol Hospital

Fundació Institut d'investigació en Ciències de la Salut Germans Trias i Pujol